Effectively advertising clinical trials open to enrollment at your research site can increase the success of your patient recruitment efforts. During this presentation, Mel Johnson, Marketing Director at Forte Research Systems will outline the basics of advertising a clinical trial to potential study participants, focusing on the steps necessary to determine your target audience and create engaging advertising materials.
Johnson will discuss strategies for posting on social media, examine when and where specific advertising materials are appropriate, and explain how your organization can build a strong online presence. Guest presenters, Wendy Tate, Director of Data Analytics at Nimblify Inc., and Beth Harper of Clinical Performance Partners will also add their expertise to the discussion. During the presentation, Tate will discuss when it is necessary to gain regulatory approval for recruitment materials as well as best practices for working with your IRB. Harper will add her insight on operational factors to consider when advertising for patient recruitment.
During this webinar you will learn:
About the Presenters:
Mel Johnson is the Director of Marketing at Forte Research Systems and Nimblify, where she is responsible for the branding, communication, lead development, and overall marketing strategy for both companies. Prior to the clinical trial industry, Mel led B2B marketing teams in the ever-changing SaaS industry. Through thought leadership and customer education, the marketing team strives to help customers streamline research operations and ultimately bring preventions and therapies to market faster.
Wendy Tate, PhD, MS, is the Director of Data Analytics for Nimblify. Wendy’s work is focused on the analytical evaluation of clinical research administration, including the development and testing of quantitative methods to measure and assess protocol feasibility and workload. Prior to Nimblify and Forte, Wendy spent 15 years at the University of Arizona in various roles within human laboratory, human subjects protection, and clinical research roles, including leadership roles with the IRB and Cancer Center clinical trials office. She received her MS in Applied Biosciences from the University of Arizona in 2005 and PhD in Pharmaceutical Sciences with an emphasis in Pharmaceutical Economics, Policy, and Outcomes and a minor in Epidemiology from the University of Arizona in 2016.
Beth is the President of Clinical Performance Partners, Inc., a clinical research consulting firm specializing in enrollment and site performance management. She has passionately pursued solutions for optimizing protocols, enhancing patient recruitment and retention and improving sponsor and site relationships for 30 years. Beth is an Adjunct Assistant Professor at the George Washington University who has published and presented extensively in the areas of study feasibility, site selection, patient recruitment, sponsor-site relationship management and protocol optimization. Beth received her B. S. in Occupational Therapy from the University of Wisconsin and an M.B.A. from the University of Texas.